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ABSTRACT 
Single events MON 87708 and MON 89788 were combined to produce the stack two-event soybean MON 
87708 × MON 89788. The EFSA GMO Panel previously assessed the two single events and did not identify 
safety concerns in the context of their scope. No new data on single soybean events leading to a modification of 
the original conclusions on their safety were identified. Agronomic and phenotypic characteristics, as well as 
compositional data of soybean MON 87708 × MON 89788, did not give rise to food/feed and environmental 
safety concerns. The EFSA GMO Panel considers that there is no reason to expect interactions between the 
single events that could impact on the food and feed safety and the nutritional properties of soybean MON 
87708 × MON 89788. There are no indications of an increased likelihood of establishment and spread of feral 
soybean plants. Considering the scope of application EFSA-GMO-NL-2012-108, potential interactions with the 
biotic and abiotic environment were not considered to be a relevant issue. The unlikely but theoretically possible 
transfer of the recombinant genes from soybean MON 87708 × MON 89788 to environmental bacteria does not 
give rise to any safety concern. The post-market environmental monitoring plan and reporting intervals are in 
line with the scope. In conclusion, the EFSA GMO Panel considers that the information available for soybean 
MON 87708 × MON 89788 addresses the scientific comments raised by Member States and that the soybean 
MON 87708 × MON 89788, as described in this application, is as safe as its non-GM comparator and non-GM 
soybean reference varieties with respect to potential effects on human and animal health and the environment in 
the context of its scope. 
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SUMMARY 
Following the submission of application EFSA-GMO-NL-2012-108 under Regulation (EC) 
No 1829/2003 from Monsanto, the Panel on Genetically Modified Organisms of the European Food 
Safety Authority (EFSA GMO Panel) was asked to deliver a scientific opinion on the safety of 
herbicide-tolerant genetically modified (GM) soybean MON 87708 × MON 89788 (Unique Identifier 
MON-877Ø8-9 × MON-89788-1). The scope of application EFSA-GMO-NL-2012-108 is for food 
and feed uses, import and processing, but excludes cultivation within the European Union (EU). 
Soybean containing the single events MON 87708 (expressing DMO) and MON 89788 (expressing 
CP4 EPSPS) were assessed previously and no concerns were identified for human and animal health 
or environmental safety. No safety issue was identified by updated bioinformatic analyses, nor 
reported by the applicant concerning the two single soybean events, since the publication of the 
respective scientific opinions. Consequently, the EFSA GMO Panel considers that its previous 
conclusions on the safety of the single soybean events remain valid. 
The two-event stack soybean MON 87708 × MON 89788 was produced by conventional crossing to 
produce soybean tolerant to dicamba and glyphosate-based herbicides. The EFSA GMO Panel 
evaluated soybean MON 87708 × MON 89788 with reference to the scope and appropriate principles 
described in its guidelines for the risk assessment of GM plants and derived food and feed, the 
environmental risk assessment of GM plants and the post-market environmental monitoring of GM 
plants. The scientific evaluation of the risk assessment included molecular characterisation of the 
inserted DNA and analysis of the expression of the corresponding proteins. An evaluation of the 
comparative analyses of the compositional, agronomic and phenotypic characteristics was undertaken, 
and the safety of the newly expressed proteins and of the whole food/feed was evaluated with respect 
to potential toxicity, allergenicity and nutritional wholesomeness. An evaluation of environmental 
impacts and the post-market environmental monitoring plan was also undertaken. In accordance with 
the EFSA GMO Panel guidance document applicable to this application (EFSA GMO Panel, 2011a), 
“For GM plants containing a combination of transformation events (stacked events) the primary 
concern for risk assessment is to establish that the combination of events is stable and that no 
interactions between the stacked events, that may raise safety concerns compared to the single events, 
occur. The risk assessment of GM plants containing stacked events focuses on issues related to: a) 
stability of the inserts, b) expression of the introduced genes and their products and c) potential 
synergistic or antagonistic effects resulting from the combination of the events”. 
The molecular data establish that the transformation events stacked in soybean MON 87708 × MON 
89788 have the same molecular properties and characteristics as the single transformation events. 
Comparison of the levels of the DMO and CP4 EPSPS proteins between the stack and the 
corresponding single events did not reveal an interaction that manifests at protein or trait expression 
level. From the molecular characterisation, no indications of interactions between the events based on 
the biological functions of the newly expressed proteins were identified. 
Based on the agronomic and phenotypic characteristics of soybean MON 87708 × MON 89788 under 
the tested conditions (treated and not treated with both intended herbicides), some differences were 
observed in soybean MON 87708 × MON 89788 compared with its non-GM comparator. The 
significant differences observed in 100 seed weight were further assessed for their potential 
environmental impact. At the compositional analysis, differences in some fatty acids (equivalence 
category III and IV) and in trypsin inhibitor soybean (equivalence not established) were identified 
between MON 87708 × MON 89788 and its non-GM comparator. The EFSA GMO Panel concluded 
that none of the differences identified in the composition, agronomic and phenotypic characteristics of 
seed and forage obtained from soybean MON 87708 × MON 89788 is relevant to food and feed safety. 
The safety assessment identified no concerns regarding the potential toxicity of the newly expressed 
proteins DMO and CP4 EPSPS in soybean MON 87708 × MON 89788. No reasons were identified 
that the presence of the two proteins in combination would result in interactions producing effects 
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different from those of the individual proteins. Similarly, the EFSA GMO Panel did not identify 
indications of safety concerns regarding allergenicity of the individual newly expressed proteins or 
their mixture in soybean MON 87708 × MON 89788, or regarding potential changes in its overall 
allergenicity. Soybean MON 87708 × MON 89788 is as nutritious as its non-GM comparator and non-
GM soybean reference varieties. 
Considering the scope of application EFSA-GMO-NL-2012-108, there is no requirement for scientific 
information on possible environmental effects associated with the cultivation of soybean MON 
87708 × MON 89788 in Europe. There are no indications of an increased likelihood of establishment 
and spread of feral soybean MON 87708 × MON 89788 plants in case of accidental release into the 
environment of viable GM soybean seeds. Potential interactions of soybean MON 87708 × MON 
89788 with the biotic and abiotic environment were not considered to be a relevant issue by the EFSA 
GMO Panel. The unlikely but theoretically possible transfer of the recombinant genes from soybean 
MON 87708 × MON 89788 to environmental bacteria does not give rise to safety concerns owing to 
the lack of a selective advantage in the context of the scope of this application. The post-market 
environmental monitoring plan provided by the applicant and the reporting intervals are in line with 
the scope of application EFSA-GMO-NL-2012-108. 
In delivering its scientific opinion, the EFSA GMO Panel took into account application EFSA-GMO-
NL-2012-108, additional information provided by the applicant, scientific comments submitted by the 
Member States and relevant scientific publications. In conclusion, the EFSA GMO Panel is of the 
opinion that the two-event stack soybean MON 87708 × MON 89788, as described in this application, 
is as safe as its non-GM comparator and non-GM soybean reference varieties with respect to potential 
effects on human and animal health and the environment in the context of its scope. 
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BACKGROUND 
On 29 March 2012, the European Food Safety Authority (EFSA) received from the Competent 
Authority of the Netherlands application EFSA-GMO-NL-2012-108, for authorisation of genetically 
modified (GM) soybean MON 87708 × MON 89788 submitted by Monsanto within the framework of 
Regulation (EC) No 1829/20034 for food and feed uses, import and processing. 
After receiving the application EFSA-GMO-NL-2012-108 and in accordance with Articles 5(2)(b) and 
17(2)(b) of Regulation (EC) No 1829/2003, EFSA informed Member States and the European 
Commission, and made the summary of the application available to the public on the EFSA website.5 
EFSA initiated a formal review of the application to check compliance with the requirements laid 
down in Articles 5(3) and 17(3) of Regulation (EC) No 1829/2003. On 29 June 2012 and on 19 July 
2012 EFSA received additional information (requested on 24 May 2012 and 19 July 2012, 
respectively). On 20 July 2012, EFSA declared the application valid in accordance with Articles 6(1) 
and 18(1) of Regulation (EC) No 1829/2003. 
EFSA made the valid application available to Member States and the European Commission, and 
consulted nominated risk assessment bodies of Member States, including national Competent 
Authorities within the meaning of Directive 2001/18/EC6 following the requirements of Articles 6(4) 
and 18(4) of Regulation (EC) No 1829/2003 to request their scientific opinion. Member States had 
three months after the date of receipt of the valid application to make their opinion known (Member 
States three months period for application EFSA-GMO-NL-2012-108 was opened on 26 September 
2013 following the finalisation of the risk assessment of the single events; the commenting period 
lasted till 8 January 2014). 
The EFSA GMO Panel carried out an evaluation of the scientific risk assessment of soybean MON 
87708 × MON 89788 for food and feed uses, import and processing in accordance with Articles 6(6) 
and 18(6) of Regulation (EC) No 1829/2003. The EFSA GMO Panel took into account the appropriate 
principles described in its guidelines for the risk assessment of GM plants and derived food and feed 
(EFSA GMO Panel, 2011a), the environmental risk assessment of GM plants (EFSA GMO Panel, 
2010b) and on the post-market environmental monitoring of GM plants (EFSA GMO Panel, 2011b). 
Furthermore, the EFSA GMO Panel also took into consideration the scientific comments of Member 
States, the additional information provided by the applicant and relevant scientific publications. 
On 13 August 2013, 6 December 2013, 10 February 2014, 5 June 2014 and 9 January 2015 the EFSA 
GMO Panel requested additional information from the applicant. The applicant provided the requested 
information on 2 September 2013, 20 December 2013, 19 February 2014, 20 June 2014 and on 
27 January 2015. The applicant also spontaneously provided additional information on 28 March 
2014, on 12 December 2014 and on 3 March 2015. The applicant requested clarifications on 
13 October 2014 and 27 January 2015. EFSA provided clarifications to the applicant on 7 November 
2014 and on 16 April 2015, respectively. 
In giving its scientific opinion to the European Commission, the Member States and the applicant, and 
in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA has endeavoured 
to respect a time limit of six months from the acknowledgement of the valid application. As additional 
information was requested by the EFSA GMO Panel, the time limit of six months was extended 
accordingly, in line with Articles 6(1), 6(2), 18(1), and 18(2) of Regulation (EC) No 1829/2003. 
                                                     
4
  Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically 
modified food and feed. OJ L 268, 18.10.2003, p. 1–23. 
5
  Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2012-00442   
6
  Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the 
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. OJ L 106, 12.3.2001, p. 1–38. 
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According to Regulation (EC) No 1829/2003, this scientific opinion is to be seen as the report 
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall 
opinion in accordance with Articles 6(5) and 18(5). 
TERMS OF REFERENCE 
The EFSA GMO Panel was requested to carry out a scientific assessment of soybean MON 
87708 × MON 89788 for food and feed uses, import and processing in accordance with Articles 6(6) 
and 18(6) of Regulation (EC) No 1829/2003. 
Where applicable, any conditions or restrictions which should be imposed on the placing on the 
market and/or specific conditions or restrictions for use and handling, including post-market 
monitoring requirements based on the outcome of the risk assessment and, in the case of GMOs or 
food/feed containing or consisting of GMOs, conditions for the protection of particular 
ecosystems/environment and/or geographical areas should be indicated in accordance with Articles 
6(5)(e) and 18(5)(e) of Regulation (EC) No 1829/2003. 
The EFSA GMO Panel was not requested to give an opinion on information required under Annex II 
to the Cartagena Protocol. Furthermore, the EFSA GMO Panel did not consider proposals for labelling 
and methods of detection (including sampling and the identification of the specific transformation 
event in the food/feed and/or food/feed produced from it), which are matters related to risk 
management.  
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ASSESSMENT 
1. Introduction 
Application EFSA-GMO-NL-2012-108 covers a two-event stack soybean MON 87708 × MON 89788 
produced by conventional crossing. The scope of this application is for food and feed uses, import and 
processing, but excludes cultivation within the European Union (EU). 
European Food Safety Authority (EFSA) guidance establishes the principle that “For GM plants 
containing a combination of transformation events (stacked events) the primary concern for risk 
assessment is to establish that the combination of events is stable and that no interactions between the 
stacked events, that may raise safety concerns compared to the single events, occur. The risk 
assessment of GM plants containing stacked events focuses on issues related to: a) stability of the 
inserts, b) expression of the introduced genes and their products and c) potential synergistic or 
antagonistic effects resulting from the combination of the events” (EFSA GMO Panel, 2011a). 
Soybean MON 87708 × MON 89788 was developed to confer tolerance to dicamba (3,6-dichloro-2-
methoxybenzoic acid) and glyphosate (N-(phosphonomethyl)glycine)-based herbicides. Dicamba 
tolerance is achieved by the expression of dicamba mono-oxygenase (DMO) protein, which 
demethylates dicamba, producing 3,6-dichlorosalicylic acid and formaldehyde. Tolerance to 
glyphosate is achieved by expression of the CP4 5-enolpyruvylshikimate-3-phosphate synthase (CP4 
EPSPS). It should be noted that the assessment of herbicide residues in soybean tolerant crops relevant 
for this application has been investigated by the EFSA Pesticides Unit (EFSA, 2009, 2013). 
The two single soybean events MON 87708 and MON 89788 have been previously assessed (see 
Table 1) on the basis of experimental data. No concerns for human and animal health or environmental 
safety were identified. 
Table 1:  Single soybean events already assessed by the EFSA GMO Panel 
Events Application or mandate EFSA Scientific Opinions 
MON 87708 EFSA-GMO-NL-2011-93 EFSA GMO Panel (2013) 
MON 89788 EFSA-GMO-NL-2006-36 EFSA (2008) 
2. Issues raised by Member States 
Issues raised by Member States on soybean MON 87708 × MON 89788 were considered in this 
scientific opinion and are addressed in detail in Annex G of the EFSA overall opinion.7 
3. Updated information on single events 
Since the publication of the scientific opinions on the single soybean events by the EFSA GMO Panel 
(EFSA, 2008; EFSA GMO Panel, 2013), no safety issue pertaining to the two single events has been 
reported by the applicant. 
Updated bioinformatic analyses8 on the junction regions for events MON 87708 and MON 89788 
confirmed that no known endogenous genes were disrupted by any of the inserts. Updated 
bioinformatic analyses9 of the amino acid sequences of the newly expressed proteins and Open 
Reading Frames in the insert and spanning the junction regions revealed no significant similarities to 
known toxins or allergens. The search for similarity to allergens used the criterion of 35 % identity to 
the amino acid sequence of known allergens in a window of 80 amino acids. No matches of eight 
contiguous identical amino acid sequences between these sequences and known allergens were found. 
                                                     
7
 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2012-00442 
8
 Additional information: 03/03/2015. 
9
 Additional information: 030/3/2015. 
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In order to conclude on the possibility of horizontal gene transfer by homologous recombination, a 
sequence identity analysis of the regions of bacterial origin of MON 87708 and MON 89788 was 
performed. In soybean MON 87708, the dicamba mono-oxygenase coding sequence (dmo) is derived 
from Stenotrophomonas maltophilia, with a total length of 1022 bp and with 99.9 % sequence identity 
to the donor organism. In addition, the left border sequence (246 bp) displays 100 % sequence identity 
with Agrobacterium tumefaciens. These two sequence identities are unlikely to represent double 
homologous recombination potential. In soybean MON 89788, no pairs of sequences with sufficient 
length of identity and correct orientation with bacterial genomes were found to facilitate the transfer of 
insert sequences to bacterial recipients by double homologous recombination. 
Having assessed the updated information on soybean MON 87708 and MON 89788, the EFSA GMO 
Panel considers that its previous conclusions on the safety of the single soybean events remain valid. 
4. Risk assessment of the two-event stack soybean MON 87708 × MON 89788 
4.1. Molecular characterisation 
Possible interactions between the known biological functions conferred by the individual inserts and 
interactions that would manifest at protein or trait expression level are considered. 
4.1.1. Genetic elements and their biological functions 
Soybean MON 87708 and MON 89788 are combined by conventional crossing to produce soybean 
MON 87708 × MON 89788. The structure of the inserts introduced into soybean MON 87708 × MON 
89788 are described in detail in the EFSA GMO Panel scientific opinions, and no new genetic 
modifications were involved. Genetic elements in the expression cassettes of the single events are 
summarised in Table 2. 
Table 2:  Genetic elements in the expression cassettes of the events stacked in soybean MON 
87708 × MON 89788 
Event Promoter 5′ UTR Transit peptide Coding region Terminator 
MON 
87708 
Full-length transcript 
promoter from Peanut 
chlorotic streak virus 
5′ UTR from 
Tobacco etch 
virus 
RbcS 
(Pisum sativum) 
dmo 
(S. maltophilia) 
3′ UTR of RbcS2 
(P. sativum) 
MON 
89788 
35S promoter from 
Figwort mosaic virus 
and promoter from the 
Tsf1 gene of 
Arabidopsis thaliana 
5′ UTR and 
intron from 
Tsf1 gene of 
A. thaliana 
ShkG 
(A. thaliana) 
CP4 epsps 
(A. tumefaciens 
strain CP4) 
3′ UTR of RbcS2 
(P. sativum) 
UTR, untranslated region. 
 
There are two newly expressed proteins in soybean MON 87708 × MON 89788, both of which are 
enzymes. Biological functions conferred by these proteins are summarised in Table 3. 
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Table 3:  Biological functions related to the events stacked in soybean MON 87708 × MON 89788 
Event Protein Function in donor organism Function in GM plant 
MON 87708 DMO Donor organism: S. maltophilia 
strain DI-6. 
DMO is an enzyme that catalyses 
the demethylation of dicamba to 
the non-herbicidal compound 
3,6-dichlorosalicylic acid and 
formaldehyde (Herman et al., 
2005) 
DMO confers tolerance to 
dicamba-based herbicides 
MON 89788 CP4 EPSPS Donor organism: A. tumefaciens 
strain CP4. 
EPSPS is an enzyme involved in 
the shikimic acid pathway for 
aromatic amino acid biosynthesis 
in plants and microorganisms 
(Herrmann, 1995). Glyphosate is 
a competitive inhibitor of this 
enzyme 
The bacterial CP4 EPSPS confers 
tolerance to glyphosate-based 
herbicides as it has a greatly 
reduced affinity towards 
glyphosate than the plant 
endogenous enzyme 
GM, genetically modified. 
4.1.2. Integrity of the events in soybean MON 87708 × MON 8978810 
The genetic stability of the inserted DNA over multiple generations in the single soybean events MON 
87708 and MON 89788 was demonstrated previously (EFSA, 2008; EFSA GMO Panel, 2013). 
Integrity of the events in soybean MON 87708 × MON 89788 was demonstrated by Southern analyses 
in the seventh self-pollinating generation after crossing the parental lines. 
4.1.3. Information on the expression of the inserts11 
Plants were grown at eight locations (four replicate blocks each) under field conditions in 2009 in the 
USA. The levels of DMO and CP4 EPSPS proteins in soybean MON 87708 × MON 89788 and the 
two single events were quantified by enzyme-linked immunosorbent assay. Proteins levels were 
determined in over-season leaf (OSL1 through OSL4 stages), root, forage and seed. The plants were 
treated with the intended herbicides (dicamba and/or glyphosate). Data on seed are reported and 
discussed below (Table 4). DMO and CP4 EPSPS protein levels in the two-event stack soybean were 
similar to the corresponding levels in the single-event soybean plants. 
Table 4:  Means and standard deviations (upper row) and ranges (lower row) of protein levels (µg/g 
dry weight) in seed from soybean MON 87708 × MON 89788 and from single soybean events MON 
87708 and MON 89788 
Protein MON 87708 × MON 89788 MON 87708 MON 89788 
DMO 41 (9.3) (a) 
24–63 
40 (11) (b) 
21–65 
NA 
CP4 EPSPS 93 (17) (a) 
67–140 
NA 95 (18) (a) 
64–130 
(a): N = 32. 
(b): N = 31. 
NA, not applicable. 
4.1.4. Conclusion 
The molecular data establish that the transformation events stacked in soybean MON 87708 × MON 
89788 have the same molecular properties and characteristics as the single transformation events. 
                                                     
10
 Dossier: Part II—Section A2.2.3. 
11
 Dossier: Part II—Section A3. 
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Comparison of the levels of the DMO and CP4 EPSPS proteins between the stack and the single 
events did not reveal an interaction that manifests at protein or trait expression level. The molecular 
characterisation revealed no indications of interactions between the events based on the biological 
functions of the newly expressed proteins. 
4.2. Comparative analysis 
4.2.1. Evaluation of relevant scientific data 
4.2.1.1. Choice of comparator and production of material for the comparative analysis12 
In field trials carried out in the USA in 2009, soybean MON 87708 × MON 89788 was compared with 
the Asgrow variety A3525, and, in total, 14 commercial non-GM soybean reference varieties13. The 
latter set of soybean varieties was included in the study to describe natural variability among 
commercial soybean varieties. The commercial Asgrow variety, A3525, was the soybean variety 
originally transformed to establish transformation event MON 87708, and is the progeny of soybean 
variety A3244 crossed with the soybean variety A3469. A3244 was the soybean variety originally 
transformed to establish transformation event MON 89788. Therefore, the EFSA GMO Panel 
considered A3525 to have a comparable genetic background to the genetically modified soybean and 
to be a suitable non-GM comparator. 
The field trials were performed at eight sites within the soybean cultivation areas in the USA (one 
each in Arkansas, Iowa, Kansas and Nebraska, and two each in Illinois and Indiana). At each site the 
following test materials were grown in a randomised complete block design with four replicates: 
soybean MON 87708 × MON 89788, the non-GM comparator (A3525) and three different non-GM 
soybean reference varieties, all treated with required maintenance pesticides; and soybean MON 
87708 × MON 89788 treated with both dicamba and glyphosate on top of required maintenance 
pesticides (treatment called dicamba + glyphosate). 
4.2.1.2. Statistical analysis of field trials data 
The statistical analysis of the agronomic, phenotypic and compositional data followed the 
recommendations by the EFSA GMO Panel (EFSA GMO Panel, 2010a, 2011a). This includes a test of 
difference to determine whether the GM plant is different from its comparator/conventional 
counterpart, and a test of equivalence to determine whether the GM plant falls within the range of 
natural variation estimated from the non-GM soybean reference varieties. As described in EFSA GMO 
Panel (2011a), the result of the equivalence test is categorised into four possible outcomes to facilitate 
drawing conclusions with respect to the presence or absence of equivalence. These four categories are 
category I, indicating full equivalence; category II, indicating that equivalence is more likely than non-
equivalence; category III, indicating that non-equivalence is more likely than equivalence; and 
category IV, indicating non-equivalence. 
4.2.1.3. Agronomic and phenotypic characteristics14 
The phenotypic and agronomic characteristics evaluated15 were early stand count, seedling vigour, 
days to 50 % flowering, flower colour, plant height, lodging, pod shattering, final stand count, seed 
moisture, 100 seed weight, yield and plant growth stages. 
In the analysis of soybean MON 87708 × MON 89788 not treated with dicamba + glyphosate, the test 
of difference of phenotypic and agronomic characteristics identified statistically significant differences 
                                                     
12
 Dossier: Part II—Sections A3.1, A3.2; additional information: 02/09/2013 and 20/06/2014. 
13
 The commercial non-GM soybean reference varieties included in the field trials were Channel Bio 3461, Channel Bio 
37002, Croplan HT3596STS, Crows C37003N, Crows C3908, FS 3591, Garst 3585N, Midland 363, NK S38-T8, NK 
32Z3, Pioneer 93M52, Quality Plus 365C, Stewart SB3454 and Wilken 3316.  
14
 Dossier: Part II—Section A3.4; additional information: 02/09/2013, 19/02/2014 and 20/06/2014. 
15
 Flower colour and plant growth stages were not statistically analysed using the most recent EFSA methodology (EFSA, 
2010a, 2011a). 
Scientific Opinion on GM soybean MON 87708 × MON 89788
 
EFSA Journal 2015;13(6):4136 11 
between soybean MON 87708 × MON 89788 and its non-GM comparator for three endpoints (seed 
moisture, 100 seed weight and yield). The test of equivalence on soybean MON 87708 × MON 89788 
(not treated with dicamba + glyphosate) showed that seed moisture and yield fell under equivalence 
category I, and 100 seed weight fell under equivalence category II. The test of equivalence could not 
be performed for seedling vigour (due to the small variation among the non-GM soybean reference 
varieties for this endpoint); however, no significant difference was identified for this endpoint. For 
seed moisture, for which a significant genotype × environment interaction had been detected, no 
consistent relationship to descriptive site characteristics was observed. 
In the analysis of soybean MON 87708 × MON 89788 treated with dicamba + glyphosate, the test of 
difference identified statistically significant differences between soybean MON 87708 × MON 89788 
and its non-GM comparator for six endpoints (early stand count, seedling vigour, days to 50 % 
flowering, plant height, 100 seed weight and yield). The equivalence test showed that five of these 
endpoints fell under equivalence category I, and the endpoint 100 seed weight fell under equivalence 
category II. The test of equivalence could not be performed for seedling vigour (due to the small 
variation among the non-GM soybean reference varieties); however, the difference in seedling vigour 
between the GM soybean and the non-GM comparator was small (3.4 vs. 3.0), and in all cases the 
vigour grading for this soybean remained normal to excellent. For 100 seed weight, for which a 
significant genotype × environment interaction had been detected, no consistent relationship to 
descriptive site characteristics was observed. 
As for 100 seed weight, full equivalence with the range of non-GM reference varieties could not be 
demonstrated (for either of the two spraying regimens) and, because this endpoint is relevant for the 
assessment of possible changes in persistence and invasiveness of the GM soybean, the significant 
differences observed in 100 seed weight are further assessed for their potential environmental impact 
in Section 4.4. 
Data on environmental interaction of soybean MON 87708 × MON 89788 compared with the non-GM 
comparator were obtained for materials that had received equivalent maintenance pesticide treatments, 
i.e. they were not treated with dicamba and glyphosate. The studies included plant response (damage) 
to three abiotic stressors, three diseases and three arthropods at each field trial site four times during 
the growing season. Comparable responses to abiotic stressors, such as cold, compaction, drought, 
flood, frost, hail, nutrient deficiency and wind, were observed. There were also no differences 
observed between soybean MON 87708 × MON 89788 and the non-GM comparator for any of the 
diseases on this legume crop. A few differences were observed for arthropod damage (see 
Section 4.4). 
4.2.1.4. Compositional analysis16 
The EFSA GMO Panel has already assessed data on the composition of soybean MON 87708 and 
MON 89788 (treated and untreated with target herbicides) as compared with their corresponding 
conventional counterparts (EFSA, 2008; EFSA GMO Panel, 2013). It was concluded that the 
composition of both soybean MON 87708 and soybean MON 89788 was comparable to that of their 
conventional counterparts (A3525 and A3244, respectively) and commercial soybean varieties. 
Soybean MON 87708 × MON 89788 forage and seeds harvested from the field trials were analysed 
for 63 constituents (56 in seeds17 and seven in forage18), including the key constituents recommended 
                                                     
16
 Dossier: Part II— Section A3.3; additional information: 02/09/2013, 20/6/2014 and 27/01/2015. 
17
 Proximates (protein, fat, ash, moisture, and carbohydrates by calculation), fibre fractions (acid detergent fibre and neutral 
detergent fibre), amino acids (alanine, arginine, aspartic acid, cysteine, glutamic acid, glycine, histidine, isoleucine, 
leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine), fatty acids (caprylic 
acid (C8:0), capric acid (C10:0), lauric acid (C12:0), myristic acid (C14:0), myristoleic acid (C14:1), pentadecanoic acid 
(C15:0), pentadecenoic acid (C15:1), palmitic acid (C16:0), palmitoleic acid (C16:1), heptadecanoic acid (C17:0), 
heptadecenoic acid (C17:1), stearic acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2), linolenic acid (C18:3), linolenic 
acid (C18:3), arachidic acid (C20:0), eicosenoic acid (C20:1), eicosadienoic acid (C20:2), eicosatrienoic acid (C20:3), 
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by OECD (2001). Seventeen seed constituents with more than 50 % of the observations below the 
limit of quantification were excluded from the statistical analysis19. 
The test of difference between compositional data of soybean MON 87708 × MON 89788 not sprayed 
with dicamba + glyphosate and the non-GM comparator (A3525) identified statistically significant 
differences for 17 constituents (15 in seeds20 and two in forage21). 
The test of equivalence between compositional data from soybean MON 87708 × MON 89788 (not 
sprayed with dicamba + glyphosate) and the non-GM soybean reference varieties indicated that the 
levels of 16 of the 17 constituents fell under equivalence category I or II, while the level of the seed 
constituent palmitic acid (% total fatty acid (FA)) fell under equivalence category III (Table 5). For 5 
of the 17 significantly different endpoints22, a significant genotype × environment interaction was 
identified. 
For soybean MON 87708 × MON 89788 sprayed with dicamba + glyphosate, statistically significant 
differences were identified for 19 constituents (16 in seeds23 and three in forage24). 
The test of equivalence between compositional data on soybean MON 87708 × MON 89788 sprayed 
with dicamba + glyphosate and the non-GM soybean reference varieties indicated that the levels of 17 
of the 19 constituents fell under equivalence category I or II. The level of the seed constituent palmitic 
acid (%FA) fell under equivalence category III, while for trypsin inhibitor the test of equivalence 
could not be performed because of the small variation among the non-GM soybean references varieties 
(Table 5). For 7 of the 19 significantly different endpoints25, a significant genotype × environment 
interaction was identified. 
Upon request from the EFSA GMO Panel, the applicant provided a statistical analysis of the fatty acid 
profile on a dry weight (% dw) basis26. In the outcome of the analysis, the level of palmitic acid in the 
GM soybean (both sprayed and not sprayed with dicamba + glyphosate) was significantly different 
and fell under equivalence category I. The levels of oleic acid (GM soybean not sprayed with 
dicamba + glyphosate) and behenic acid (GM soybean both sprayed and not sprayed with 
dicamba + glyphosate) measured in % dw were significantly different and fell under equivalence 
category IV (Table 5). 
 
 
                                                                                                                                                                     
arachidonic acid (C20:4) and behenic acid (C22:0)), vitamin E, anti-nutrients (phytic acid, trypsin inhibitor, lectins, 
stachyose and raffinose) and other secondary metabolites (isoflavones: daidzein, genistein and glycitein). 
18
 Proximates: protein, fat, ash, moisture, and carbohydrates by calculation; fibre fractions: acid detergent fibre and neutral 
detergent fibre. 
19
 Caprylic acid (C8:0), capric acid (C10:0), lauric acid (C12:0), myristic acid (C14:0), myristoleic acid (C14:1), 
pentadecanoic acid (C15:0), pentadecenoic acid (C15:1), palmitoleic acid (C16:1), heptadecanoic acid (C17:0), 
heptadecenoic acid (C17:1), gamma-linolenic acid (C18:3), eicosadienoic acid (C20:2), eicosatrienoic acid (C20:3) and 
arachidonic acid (C20:4). 
20
 Protein and moisture; the amino acids arginine, cystine and proline; the fatty acids palmitic acid (C16:0), stearic acid 
(C18:0), oleic acid (C18:1), linoleic acid (C18:2), arachidic acid (C20:0) and behenic acid (C22:0); the anti-nutrients 
raffinose and stachyose; and the isoflavones genistein and daidzein. 
21
 Carbohydrates and fat. 
22
 Seed levels of protein, palmitic acid (C16:0), oleic acid (C18:1), linoleic acid (C18:2) and stachyose. 
23
 Protein, moisture and ash; the amino acids arginine, cystine and proline; the fatty acids palmitic acid (C16:0), stearic acid 
(C18:0), oleic acid (C18:1), linoleic acid (C18:2), arachidic acid (C20:0) and behenic acid (C22:0); the anti-nutrients 
raffinose and stachyose; and the isoflavones genistein and daidzein. 
24
 Carbohydrates, protein and fat. 
25
 Seed levels of protein, arginine, cystine, palmitic acid (C16:0), linoleic acid (C18:2), behenic acid (C22:0) and stachyose. 
26
 Additional information: 27/01/2015. 
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Table 5:  Compositional endpoints that are further discussed based on the results of the statistical 
analysis: means (for the non-GM comparator and the GM soybean) and equivalence limits (from the 
non-GM reference varieties) estimated from field trials data collected in 2009. Significantly different 
entries are marked with a star. The outcomes of the test of equivalence are differentiated by greyscale 
backgrounds: white (the test of equivalence could not be performed), light grey (equivalence category 
III) and dark grey (equivalence category IV) 
Endpoint Comparator 
(A3525, 
untreated) 
Soybean MON 87708 × MON 89788 Equivalence limits 
from non-GM 
soybean reference 
varieties (untreated) 
Untreated (a) Treated (b) 
Palmitic acid (16:0) 
(% FA) (c) 
11.74 12.17* 12.12* (9.48, 12.08) 
Oleic acid (18:1) 
(% dw) 
2.97 2.81* 2.87 (3.00, 4.32) 
Behenic acid (22:0) 
(% dw) 
0.045 0.048* 0.049* (0.052, 0.060) 
Trypsin inhibitor 
(TIU/mg dw) 
35.32 35.08 38.71* Not applied 
(a): Untreated: soybean MON 87708 × MON 89788 not sprayed with the target herbicides (dicamba + glyphosate). 
(b): Treated: soybean MON 87708 × MON 89788 sprayed with the target herbicides (dicamba + glyphosate). 
(c): Fatty acid proportions are given as percentages of total fatty acids.  
dw, dry weight; TIU, trypsin inhibitor unit. 
The EFSA GMO Panel assessed all compositional differences between soybean MON 87708 × MON 
89788 and its non-GM comparator. After considering the well-known chemical characteristics of the 
compounds concerned, the magnitudes of the changes observed (Table 5) and denaturation of trypsin 
inhibitor by heat during processing, the EFSA GMO Panel did not identify any need for further 
assessment with regard to food and feed safety. 
For each of the parameters for which a significant genotype × environment interaction had been 
detected, no consistent relationship to descriptive site characteristics was observed. 
4.2.2. Conclusion 
Based on the agronomic and phenotypic characteristics of soybean MON 87708 × MON 89788 under 
the tested conditions (treated and not treated with both intended herbicides), some differences were 
observed in soybean MON 87708 × MON 89788 compared with its non-GM comparator. The 
significant differences observed in 100 seed weight are further assessed for their potential 
environmental impact in Section 4.4. 
The EFSA GMO Panel concluded that none of the differences identified in the agronomic and 
phenotypic characteristics and in the composition of seed and forage obtained from soybean MON 
87708 × MON 89788 required further assessment regarding food and feed safety. 
4.3. Food and feed safety assessment 
4.3.1. Effect of processing27 
Soybean MON 87708 × MON 89788 will undergo existing methods of production and processing 
used for commercial soybean. No novel method of production and processing is envisaged. 
                                                     
27
 Dossier: Part II—Section A3.5. 
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4.3.2. Toxicology 
4.3.2.1. Toxicological assessment of newly expressed proteins28 
Two proteins (DMO and CP4 EPSPS) are newly expressed in various tissues of the two-event stack 
soybean MON 87708 × MON 89788. The EFSA GMO Panel assessed these proteins previously (see 
Table 1), and no safety concerns to humans or animals were identified. The CP4 EPSPS protein has 
also been previously assessed in other GM applications (e.g. EFSA GMO Panel, 2012, 2014). The 
EFSA GMO Panel is not aware of any new information that would change these conclusions. 
The two proteins are enzymes which catalyse distinct biochemical reactions and act on unrelated 
substrates in the plant. No reasons were identified that the presence of the two proteins in combination 
would result in interactions producing effects different from those of the individual proteins (see 
Section 4.1.4). Since the individual proteins are considered safe for humans and animals (e.g. EFSA 
2008, 2013), the same conclusion can be extended to the mixture. 
4.3.2.2. Toxicological assessment of components other than newly expressed proteins29 
The compositional analysis of soybean MON 87708 × MON 89788 did not identify changes (see 
Section 4.2) that would require further assessment. 
4.3.3. Allergenicity 
For allergenicity assessment, a weight-of-evidence approach is followed, taking into account all of the 
information obtained on the newly expressed proteins, since no single piece of information or 
experimental method yields evidence to predict allergenicity (EFSA, 2006; Codex Alimentarius, 2009; 
EFSA GMO Panel, 2011a). In addition, when known functional aspects of the newly expressed 
protein or structural similarity to known adjuvants may indicate an adjuvant activity, the possible role 
of these proteins as adjuvants is considered (EFSA GMO Panel, 2011a). When newly expressed 
proteins with a potential adjuvant activity are expressed together, possible interactions increasing 
adjuvanticity and impacting the allergenicity of the GM crop are assessed. 
4.3.3.1. Assessment of allergenicity of the newly expressed proteins30 
For allergenicity, the EFSA GMO Panel has previously evaluated the safety of the DMO and CP4 
EPSPS proteins, and no concerns about allergenicity were identified in the context of the applications 
assessed (e.g. see Table 1; EFSA GMO Panel, 2012, 2014). No new information on allergenicity of 
the single events that might change the previous conclusions of the EFSA GMO Panel has become 
available. Based on current knowledge, and since none of the newly expressed proteins showed 
allergenicity, no reasons for concern regarding the mixture of these newly expressed proteins in this 
two-event stack soybean affecting allergenicity were identified. 
As regards adjuvanticity, no information available on the structure or function of the newly expressed 
DMO and CP4 EPSPS proteins would suggest an adjuvant effect of the individual proteins or their 
mixture in soybean MON 87708 × MON 89788 resulting in or increasing an eventual IgE response to 
a bystander protein. 
4.3.3.2. Assessment of allergenicity of the whole GM plant31 
Soybean is considered to be a common allergenic food32 (OECD, 2012). Therefore, any potential 
change in the endogenous allergenicity of the GM plant when compared with that of its comparator(s) 
                                                     
28
 Dossier: Part II—Section A4.2; additional information: 19/03/2013. 
29
 Dossier: Part II—Section A4.3. 
30
 Dossier: Part II—Section A5; additional information: 03/03/2015. 
31
 Dossier: Part II—Section A5; additional information: 02/09/2013 and 20/12/2013. 
32
 Directive 2007/68/EC of the European Parliament and of the Council of 27 November 2007 amending Annex IIIa to 
Directive 2000/13/EC of the European Parliament and of the Council as regards certain food ingredients. OJ L 310, 
27.11.2007, p. 11–14. 
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should be assessed (EFSA GMO Panel, 2011a). Such assessments were performed for the single 
events soybean MON 87708 and soybean MON 89788, and no reasons for concern were identified by 
the EFSA GMO Panel (EFSA, 2008; EFSA GMO Panel, 2013). 
At the request of the EFSA GMO Panel, the applicant provided an assessment of the endogenous 
allergenicity of protein extracts of soybean MON 87708 × MON 89788 and of its non-GM comparator 
(A3525) as determined by gel electrophoresis followed by mass spectrometry. The intensities of the 
bands corresponding to specific allergens were analysed. No relevant changes in the allergen content 
between the protein extracts of soybean MON 87708 × MON 89788 and of its non-GM comparator 
were identified. 
The EFSA GMO Panel considers that there is no evidence that the genetic modification might 
significantly change the overall allergenicity of soybean MON 87708 × MON 89788 when compared 
with that of its non-GM comparator. 
4.3.4. Nutritional assessment of GM food/feed 
The intended trait of soybean MON 87708 × MON 89788 is herbicide tolerance, with no intention to 
alter the nutritional parameters. Comparison of the composition of soybean MON 87708 × MON 
89788 with its conventional counterpart did not identify differences that would require a safety 
assessment (see Section 4.2). From these data, the nutritional characteristics of soybean MON 
87708 × MON 89788-derived food and feed are not expected to differ from those of conventional 
soybean varieties. 
4.3.5. Post-market monitoring of GM food/feed 
The EFSA GMO Panel considers that post-market monitoring of GM food/feed is not necessary, given 
the absence of safety concerns identified for soybean MON 87708 × MON 89788. 
4.3.6. Conclusion 
The safety assessment identified no concerns regarding the potential toxicity of the newly expressed 
proteins DMO and CP4 EPSPS in soybean MON 87708 × MON 89788. No reasons were identified 
that the presence of the two proteins in combination would result in interactions producing effects 
different from those of the individual proteins. Similarly, the EFSA GMO Panel did not identify 
indications of safety concerns regarding allergenicity of the individual newly expressed proteins or 
their mixture in soybean MON 87708 × MON 89788, or regarding potential changes in overall 
allergenicity. Soybean MON 87708 × MON 89788 is as nutritious as its non-GM comparator and non-
GM soybean reference varieties. 
4.4. Environmental risk assessment and monitoring plan 
4.4.1. Evaluation of relevant scientific data 
Considering the scope of application EFSA-GMO-NL-2012-108, the environmental risk assessment 
(ERA) of soybean MON 87708 × MON 89788 is concerned mainly with (i) exposure of bacteria to 
recombinant DNA in the gastrointestinal tract of animals fed GM material and bacteria present in 
environments exposed to faecal material; and (ii) accidental release into the environment of viable 
seeds of soybean MON 87708 × MON 89788 during transportation and processing. 
As the scope of application EFSA-GMO-NL-2012-108 excludes cultivation, environmental concerns 
in the EU related to the use of glyphosate-based and dicamba-based herbicides on the GM soybean do 
not apply. 
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4.4.2. Environmental risk assessment 
4.4.2.1. Potential unintended effects on plant fitness due to the genetic modification33 
Cultivated soybean (Glycine max (L.) Merr.) is a species in the subgenus Soja of the genus Glycine. 
The species originated from eastern Asia and is a highly domesticated crop (Lu, 2005). The major 
worldwide soybean producers are Argentina, Brazil, China, North Korea, South Korea and the USA. 
In the EU34, soybean is mainly cultivated in Italy, Romania, France, Hungary, Austria, Slovakia and 
the Czech Republic (Dorokhov et al., 2004; Krumphuber, 2008). Cultivated soybean seeds rarely 
display any dormancy characteristics, and only under certain environmental conditions grow as 
volunteers in the year following cultivation. If volunteers occur, they do not compete well with the 
succeeding crop, and can easily be controlled mechanically or chemically (OECD, 2000). In soybean 
fields, seeds usually do not survive during the winter owing to herbivory, rotting and germination 
resulting in death, or owing to management practices prior to planting the subsequent crop (Owen, 
2005). 
The herbicide tolerance traits can be regarded as providing a potential agronomic and selective 
advantage to this GM soybean plant only where and when glyphosate-based and dicamba-based 
herbicides are applied. However, survival of soybean plants outside cultivation where glyphosate-
based and dicamba-based herbicides are applied is limited mainly by a combination of low 
competitiveness, absence of a dormancy phase and susceptibility to plant pathogens and cold climatic 
conditions. Based in the inserted traits, the EFSA GMO Panel considers that these general 
characteristics are unchanged in soybean MON 87708 × MON 89788; herbicide tolerance is therefore 
unlikely to provide a selective advantage outside cultivation. Even if glyphosate-based and dicamba-
based herbicides are applied to these plants, this will not change their ability to survive over seasons. 
Therefore, it is considered very unlikely that soybean MON 87708 × MON 89788 will differ from 
conventional soybean varieties in its ability to survive until subsequent seasons or to establish feral 
populations under European environmental conditions. 
Laboratory tests and field studies have been carried out to assess the phenotypic and agronomic 
characteristics as well as environmental interactions of GM soybean as described in Section 4.2.1.3. 
Phenotypic and agronomic characteristics were evaluated in a field trial across eight locations in the 
USA in 2009. In addition, environmental interactions, such as soybean MON 87708 × MON 89788 
responses to abiotic and biotic stressors, were evaluated in the same trials (i.e. they were not treated 
with dicamba-based and glyphosate-based herbicides) (for further details, see Section 4.2.1.3). 
Considering the scope of application EFSA-GMO-NL-2012-108, special attention is paid to those 
agronomic characteristics which may affect the survival, establishment and fitness of soybean MON 
87708 × MON 89788 seeds which could be accidentally released into the environment: e.g. early and 
final stand count, seedling vigour, 100 seed weight, plant height and yield. As described in 
Section 4.2.1.3, soybean MON 87708 × MON 89788 treated and not treated with dicamba-based and 
glyphosate-based herbicides had lower 100 seed weight than its non-GM comparator. Moreover, the 
equivalence test for the 100 seed weight endpoint indicates that equivalence with non-GM reference 
varieties is more likely than not. For this reason and because this endpoint is relevant for the 
assessment of possible changes in persistence and invasiveness of the GM soybean, the significant 
differences observed in 100 seed weight are further assessed below. For 100 seed weight for which a 
significant genotype × environment interaction had been detected, no consistent relationship to 
descriptive site characteristics was observed (see Section 4.2.1.3). 
During the ERA of the single transformation event MON 87708 (EFSA GMO Panel, 2013), the EFSA 
GMO Panel also observed that “dicamba-treated and non-treated soybean MON 87708 had lower 100 
seed weight than its conventional counterpart and the non-GM reference varieties planted in these 
field trials.” The observed differences in 100 seed weight might therefore be an indication of 
                                                     
33
 Dossier: Part II—Section E3.1 and Appendix D. 
34
 http://epp.eurostat.ec.europa.eu/portal/page/portal/agriculture/data/database 
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unintended effects due to the genetic modification. Differences in seed lots quality could also explain 
such observations; however, the information included in the dossier does not indicate such an effect. 
Specific data on pollen viability, seed germination and dormancy for soybean MON 87708 × MON 
89788 were not provided by the applicant. Therefore, the EFSA GMO Panel asked the applicant to 
clarify the origin and production conditions of the test materials used, and to justify that the best 
materials allowed a proper comparative assessment. The applicant did not provide additional data but 
did provide a rationale35 for relying on seed germination data for the two single soybean events36 and 
data on the early stand count for soybean MON 87708 × MON 89788 compared with its non-GM 
comparator. The applicant concluded that “the use of MON 87708 × MON 89788 and control 
materials that had similar genetic backgrounds except for the trait of interest, and the seed 
germination characteristics already provided, demonstrate the suitability of the test and control 
materials utilized in the comparative assessment”. 
The EFSA GMO Panel therefore considered the data provided by the applicant on seed germination 
and dormancy of the single soybean events MON 89788 and MON 87708, their comparators and non-
GM reference varieties, produced under different environmental conditions (see EFSA, 2008; EFSA 
GMO Panel, 2013). No differences in seed germination of soybean MON 89788 compared with its 
conventional counterpart were observed under any controlled environmental conditions. For soybean 
MON 87708, the two differences in seed germination observed under certain controlled environmental 
conditions (i.e. at constant temperature of approximately 10 °C and at alternating temperatures of 
approximately 10 °C and 30 °C) fell within the range of commercial reference varieties. The observed 
differences showed a lower seed germination percentage for soybean MON 87708 than for its non-GM 
comparator. Moreover, the observed differences were not consistent across sites and did not indicate a 
consistent plant response associated with the herbicide tolerance trait or any change in fitness. 
Considering that available dataset on soybean MON 87708 × MON 89788, and in the light of the 
scope of application EFSA-GMO-NL-2012-108, the EFSA GMO Panel did not expect changes in the 
seed germination characteristics of soybean MON 87708 × MON 89788. 
Although the differences observed in 100 seed weight might result from the genetic modification, they 
are unlikely to be biologically relevant in terms of increased weed potential of soybean MON 
87708 × MON 89788 in the context of the scope of this application and considering that the other 
characteristics of soybean MON 87708 × MON 89788 relevant to persistence and invasiveness are not 
changed. 
In addition to the data presented by the applicant, the EFSA GMO Panel is not aware of any scientific 
report of increased spread and establishment of existing GM soybeans and any change in survival 
capacity, including overwintering (Dorokhov et al., 2004; Owen 2005; Bagavathiannan and Van 
Acker, 2008; Lee et al., 2009). 
Therefore, the EFSA GMO Panel is of the opinion that the likelihood of unintended environmental 
effects of the soybean MON 87708 × MON 89788 in Europe will not be different from that of 
conventional soybean varieties. 
4.4.2.2. Potential for gene transfer37 
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic material, 
either through horizontal gene transfer of DNA or through vertical gene flow via seed spillage 
followed by cross-pollination. 
                                                     
35
 Additional data, 18 February 2014. 
36
 Section D.4 of EFSA/GMO/NL/2006/36 and Section D.4 of EFSA/GMO/NL/2011/93. 
37
 Dossier: Part II—Sections E3.1, E3.2. 
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(a) Plant to bacteria gene transfer 
The potential for horizontal gene transfer of the recombinant DNA of the single events has already 
been assessed in previous opinions (EFSA, 2008; EFSA GMO Panel, 2013) and no concern for an 
unlikely, but theoretically possible, horizontal gene transfer of the recombinant genes to bacteria in the 
gut or other receiving environments was identified. 
Bioinformatic analyses revealed for MON 87708 two sequences with sequence identity of 
considerable length with bacterial genes in databases; the dmo coding sequence of DMO from 
S. maltophilia, with a total length of 1 022 bp and 99.9 % identity, and the left border sequence 
(246 bp) with 100 % identity to the A. tumefaciens Ti plasmid. Considering that these occur is in 
different bacterial species, there is no indication for facilitated horizontal gene transfer from plants to 
bacteria by double homologous recombination. Substitutive homologous recombination of the dmo 
gene and the left border sequence with natural variants of these sequences as they occur in 
S. maltophilia, A. tumefaciens or other environmental bacteria could be facilitated, but such events 
would not confer any novel traits on the recipients. 
For the bioinformatic analyses of MON 89788, no sequence identity with bacterial DNA, including the 
CP4 epsps gene, which was plant codon optimised, were identified. Thus, there is no indication of 
facilitated gene transfer of recombinant DNA of MON 89788 to bacteria. 
Synergistic effects of the recombinant genes in increasing the likelihood for horizontal gene transfer, 
for instance combinations of recombinogenic sequences, were not identified. Since soybean MON 
87708 × MON 89788 is produced by conventional crossing, close linkage of the different events is 
extremely unlikely. 
Therefore, in line with its previous assessments of MON 89788 and MON 87708, and considering the 
new, additional bioinformatic analyses provided by the applicant, the EFSA GMO Panel concludes 
that, considering the scope of application EFSA-GMO-NL-2012-108, the unlikely but theoretically 
possible transfer of the recombinant genes from soybean MON 87708 × MON 89788 to environmental 
bacteria does not raise a safety concern. 
(b) Plant-to-plant gene transfer 
Considering the scope of application EFSA-GMO-NL-2012-108 and the physical characteristics of 
soybean seeds, a possible pathway of gene dispersal is from seed spillage and pollen of occasional 
feral GM soybean plants originating from accidental seed spillage during transportation and/or 
processing. 
The genus Glycine is divided into two distinct subgenera: Glycine and Soja. Soybean is in the 
subgenus Soja. The subgenus Glycine contains 16 perennial wild species, while the cultivated 
soybean, G. max, and its wild and semi-wild annual relatives, Glycine soja and Glycine gracilis, are 
classified in the subgenus Soja (OECD, 2000). Owing to the low level of genomic similarity among 
species of the genus Glycine, G. max can cross only with other members of Glycine subgenus Soja 
(Hymowitz et al., 1998; Lu, 2005). Hence, the three species of the subgenus Soja are capable of cross-
pollination and the hybrid seed that is produced can germinate normally and produce plants with 
fertile pollen and seed (Abe et al., 1999; Nakayama and Yamaguchi, 2002). However, since G. soja 
and G. gracilis are indigenous to China, Taiwan, Korea, Japan, the far east region of Russia, Australia, 
the Philippines and the South Pacific, and since they have not been reported in other parts of the world 
where the cultivated soybean is grown (Dorokhov et al., 2004; Lu, 2005), the plant-to-plant gene 
transfer from soybean is restricted to cultivated areas and the occasional soybean plants resulting from 
seed spillage in the EU. 
Soybean is an annual almost completely self-pollinating crop in the field, and its percentage of cross-
pollination is usually lower than 1 % (Weber and Hanson, 1961; Caviness, 1966; Ray et al., 2003; Lu, 
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2005; Yoshimura et al., 2006; Abud et al., 2007). Soybean pollen dispersal is limited because the 
anthers mature in the bud and directly pollinate the stigma of the same flower (OECD, 2000). 
However, cross-pollination rates as high as 6.3 % have been reported for closely spaced plants (Ray et 
al., 2003), suggesting the potential for some within-crop gene flow in soybean. These results indicate 
that natural cross-pollination rates can fluctuate significantly among different soybean varieties under 
particular environmental conditions, such as favourable climate for pollination and an abundance of 
pollinators (Gumisiriza and Rubaihayo, 1978; Kikuchi et al., 1993; Ahrent and Caviness, 1994; Ray et 
al., 2003; Lu, 2005). 
Plant-to-plant gene flow could therefore occur under the following scenario: imports of soybean MON 
87708 × MON 89788 seeds (although most MON 89788 × MON 87708 seeds will be processed in 
countries of production), processing outside importing ports, transport in regions of soybean 
production in Europe, spillage of GM seeds during transport, germination and development of spilled 
seeds within soybean fields or in the very close vicinity of cultivated soybean fields, overlap of 
flowering periods and particular environmental conditions favouring cross-pollination. The overall 
likelihood of cross-pollination between GM soybean plants and cultivated soybean is therefore 
extremely low. Except in seed production areas, such plants will not persist over time. Dispersal of 
soybean seeds by animals is not expected because of the characteristics of the seed, but accidental 
release into the environment of seeds may occur during transport and processing for food, feed and 
industrial uses. However, cultivated soybean seeds rarely display any dormancy characteristics and 
only under certain environmental conditions grow as volunteers in the year following cultivation 
(OECD, 2000). Even in soybean fields, seeds usually do not survive during the winter because of 
predation, rotting or germination resulting in death, or as a result of management practices prior to 
planting the subsequent crop (Owen, 2005). 
The EFSA GMO Panel takes into account that this application does not include cultivation of the 
soybean within the EU so that the likelihood of cross-pollination between cultivated soybean and the 
occasional soybean plants resulting from seed spillage is considered extremely low. However, in 
countries cultivating this GM soybean and producing seed for export, there is a potential for admixture 
in seed production and thus the introduction of GM seeds through this route. Hence, it is important 
that appropriate management systems are in place to restrict seeds of soybean MON 87708 × MON 
89788 entering cultivation as this would require specific approval under Directive 2001/18/EC or 
Regulation (EC) No 1829/2003. 
In conclusion, as soybean MON 87708 × MON 89788 has no altered survival, multiplication or 
dissemination characteristics, the EFSA GMO Panel is of the opinion that the likelihood of unintended 
environmental effects as a consequence of spread of genes from this GM soybean in Europe will not 
differ from that of conventional soybean varieties. 
4.4.2.3. Potential interactions of the GM plant with target organisms38 
Considering the scope of application EFSA-GMO-NL-2012-108, and in the absence of target 
organisms, potential interactions of the GM plant with target organisms were not considered a relevant 
issue by the EFSA GMO Panel. 
4.4.2.4. Potential interactions of the GM plant with non-target organisms39 
Considering the scope of application EFSA-GMO-NL-2012-108, and the low level of exposure to the 
environment, potential interactions of the GM plant with non-target organisms were not considered a 
relevant issue by the EFSA GMO Panel. 
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4.4.2.5. Potential interactions with the abiotic environment and biogeochemical cycles40 
Considering the scope of application EFSA-GMO-NL-2012-108, and the low level of exposure to the 
environment, potential interactions with the abiotic environment and biogeochemical cycles were not 
considered a relevant issue by the EFSA GMO Panel. 
4.4.3. Post-market environmental monitoring41 
The objectives of a post-market environmental monitoring plan according to Annex VII of Directive 
2001/18/EC are (1) to confirm that any assumption regarding the occurrence and impact of potential 
adverse effects of the GMO, or its use, in the ERA are correct and (2) to identify the occurrence of 
adverse effects of the GMO, or its use, on human health or the environment that were not anticipated 
in the ERA. 
Monitoring is related to risk management, and thus a final adoption of the post-market environmental 
monitoring plan falls outside the mandate of EFSA. However, the EFSA GMO Panel gives its opinion 
on the scientific content of the post-market environmental monitoring plan provided by the applicant 
(EFSA, 2006; EFSA GMO Panel, 2011b). The potential exposure to the environment of soybean 
MON 87708 × MON 89788 would be through faecal material from animals fed the GM soybean or 
through accidental release into the environment of GM soybean seeds during transportation and 
processing. The EFSA GMO Panel is aware that, owing to the physical characteristics of soybean 
seeds and methods of transportation, accidental spillage cannot be excluded. Hence, it is important that 
appropriate management systems are in place to restrict seeds of soybean MON 89788 × MON 87708 
entering cultivation as this would require specific approval under Directive 2001/18/EC or Regulation 
(EC) No 1829/2003. 
The post-market environmental monitoring plan proposed by the applicant includes (1) the description 
of an approach involving operators (federations involved in soybean import and processing) reporting 
to the applicant via a centralised system any observed adverse effect(s) of GMOs on human health and 
the environment; (2) a coordinating system established by EuropaBio for the collection of the 
information recorded by the various operators; and (3) the use of networks of existing surveillance 
systems (Lecoq et al. 2007; Windels et al., 2008). The applicant proposes to submit a post-market 
environmental monitoring report on an annual basis and a final report at the end of the consent. 
The EFSA GMO Panel is of the opinion that the post-market environmental monitoring plan proposed 
by the applicant is in line with the scope of application EFSA-GMO-NL-2012-108 as the ERA did not 
cover cultivation and identified no potential adverse environmental effects. No case-specific 
monitoring is necessary. The EFSA GMO Panel agrees with the reporting intervals proposed by the 
applicant in its post-market environmental monitoring plan. 
4.4.4. Conclusion 
Considering the scope of application EFSA-GMO-NL-2012-108, there are no indications of an 
increased likelihood of establishment and spread of feral soybean MON 87708 × MON 89788 plants 
in the case of accidental release into the environment of viable GM soybean seeds. Potential 
interactions of soybean MON 87708 × MON 89788 with the biotic and abiotic environment were not 
considered a relevant issue by the EFSA GMO Panel. The unlikely but theoretically possible transfer 
of the recombinant genes from soybean MON 87708 × MON 89788 to environmental bacteria does 
not give rise to a safety concern owing to the lack of a selective advantage in the context of the scope 
of this application. The post-market environmental monitoring plan provided by the applicant and the 
reporting intervals are in line with the scope of application EFSA-GMO-NL-2012-108. 
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OVERALL CONCLUSIONS AND RECOMMENDATIONS 
No new data on the single soybean events MON 89788 and MON 87708 that would lead to a 
modification of the original conclusions on their safety were identified. 
The combination of soybean single events MON 89788 and MON 87708 in the two-event stack 
soybean MON 87708 × MON 89788 did not give rise to issues—relating to molecular, agronomic, 
phenotypic or compositional characteristics—regarding food and feed safety. The EFSA GMO Panel 
considers that there is no reason to expect interactions that could impact on the food and feed safety 
and nutritional properties. The compositional data indicate that soybean MON 87708 × MON 89788 
would be expected to deliver the same nutrition as its non-GM comparator. 
Considering the scope of application EFSA-GMO-NL-2012-108, there are no indications of an 
increased likelihood of establishment and spread of feral soybean MON 87708 × MON 89788 plants 
in the case of accidental release into the environment of viable GM soybean seeds. Potential 
interactions of soybean MON 87708 × MON 89788 with the biotic and abiotic environment were not 
considered a relevant issue by the EFSA GMO Panel. The unlikely but theoretically possible transfer 
of the recombinant genes from soybean MON 87708 × MON 89788 to environmental bacteria does 
not give rise to a safety concern owing to the lack of a selective advantage in the context of the scope 
of this application. The post-market environmental monitoring plan provided by the applicant and the 
reporting intervals are in line with the scope of application EFSA-GMO-NL-2012-108. 
In conclusion, the EFSA GMO Panel considers that the information available for soybean MON 
87708 × MON 89788 addresses the scientific comments raised by Member States and that the soybean 
MON 87708 × MON 89788, as described in this application, is as safe as its non-GM comparator and 
non-GM soybean reference varieties with respect to potential effects on human and animal health and 
the environment in the context of its scope. 
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CORRESPONDENCE 
1. Letter from Competent Authority of the Netherlands received on 29 March 2012 concerning a 
request for authorisation for the placing on the market of soybean MON 87708 × MON 89788 
(application EFSA-GMO-NL-2012-108) submitted in accordance with Regulation (EC) No 
1829/2003 by Monsanto Europe S.A./N.V. 
2. Acknowledgement letter dated 12 April 2012 from EFSA to the Competent Authority of the 
Netherlands. 
3. Letter from EFSA to applicant dated 24 May 2012 requesting additional information under 
completeness check. 
4. Letter from applicant to EFSA received on 29 June 2012 providing additional information under 
completeness check. 
5. Email from APDESK to applicant sent on 19 July 2012 providing clarifications. 
6. Email from applicant to APDESK received on 19 July 2012 providing clarifications. 
7. Letter from EFSA to applicant dated 20 July 2012 delivering the ‘Statement of Validity’ of 
application EFSA-GMO-NL-2012-108 (soybean MON 87708 × MON 89788) submitted by 
Monsanto Europe S.A./N.V under Regulation (EC) No 1829/2003. 
8. Letter from EFSA to applicant dated 24 July 2012 stopping the clock due to single event. 
9. Letter from EFSA to applicant dated 13 August 2013 requesting additional information and 
maintaining the clock stopped. 
10. Letter from applicant to EFSA received on 2 September 2012 providing additional information 
upon the request dated 13 August 2012. 
11. Letter from applicant to EFSA received on 2 September 2013 providing additional information 
spontaneously. 
12. Letter EFSA to applicant dated 23 September 2013 re-starting the clock due to single event but 
maintaining the clock stopped pending EFSA’s questions. 
13. Letter from EFSA to applicant dated 6 December 2013 requesting additional information and 
maintaining the clock stopped. 
14. Letter from applicant to EFSA received on 20 December 2013 providing additional information. 
15. Letter from EFSA to applicant dated 10 February 2014 requesting additional information and 
maintaining the clock stopped. 
16. Letter from applicant to EFSA received on 19 February 2014 providing additional information. 
17. Letter from applicant to EFSA received on 28 March 2014 providing additional information 
spontaneously. 
18. Letter from EFSA to applicant dated 5 June 2014 requesting additional information and 
maintaining the clock stopped. 
19. Letter from applicant to EFSA received on 20 June 2014 providing additional information. 
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20. Letter from applicant to EFSA received on 13 October 2014 asking clarifications on the progress 
of the application. 
21. Letter from EFSA to applicant dated 15 October 2014 re-starting the clock. 
22. Letter from EFSA to applicant dated 7 November 2014 providing clarifications on the progress of 
the application. 
23. Letter from applicant to EFSA received on 12 December 2014 providing additional information 
spontaneously. 
24. Letter from EFSA to applicant dated 9 January 2015 requesting additional information and 
stopping the clock. 
25. Letter from applicant to EFSA received on 27 January 2015 providing additional information. 
26. Letter from applicant to EFSA received on 27 January 2015 asking clarifications on the progress 
of the application. 
27. Letter from applicant to EFSA received on 3 March 2015 providing additional information 
spontaneously. 
28. Letter from EFSA to applicant dated 25 March 2014 re-starting the clock. 
29. Letter from EFSA to applicant dated 16 April 2015 providing clarifications on the progress of the 
application. 
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